When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Última revisão: 19 Mar 2025
Última atualização: 20 Nov 2024

Resumo

Definição

História e exame físico

Principais fatores diagnósticos

  • redução de débito urinário
  • hemoptise
  • edema

Outros fatores diagnósticos

  • sexo masculino
  • 20 a 30 ou 60 a 70 anos de idade
  • dispneia
  • tosse
  • febre
  • náuseas
  • estertores no exame pulmonar

Fatores de risco

  • HLA-DRB1 ou DR4
  • tabagismo
  • exposição a hidrocarbonetos, solventes orgânicos, metais pesados
  • história de litotripsia
  • infecções respiratórias recentes
  • imunoterapia
  • após transplante renal em pacientes com síndrome de Alport

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • teste da função renal
  • biópsia renal
  • título de anticorpo antimembrana basal glomerular (anti-GBM)
  • anticorpo anticitoplasma de neutrófilo (ANCA)
  • complemento sérico (C3 e C4)
  • fator antinuclear (FAN)
  • crioglobulinas
  • painel de hepatite
  • título de antiestreptolisina O
  • exames de coagulação

Algoritmo de tratamento

Colaboradores

Autores

Tingting Li, MD, MSCI, FASN

Professor of Medicine

Director, Glomerular Diseases Program

Division of Nephrology

Washington University School of Medicine in St Louis

St Louis

MO

Declarações

TL receives research support from Travere Therapeutics, Omeros Corporation, and the US NIH/NIAID, and reports consultancy agreements with ChemoCentryx, Travere Therapeutics, Amgen, Aurinia Pharmaceuticals, Calliditas Therapeutics, and GlaxoSmithKline. She also serves as a board member of GlomCon and a member of the ASN Publications Committee.

Christina Mariyam Joy, MD

Assistant Professor of Medicine

Division of Nephrology

Froedtert and Medical College of Wisconsin

Milwaukee

WI

Declarações

CMJ declares that she has no competing interests.

Agradecimentos

Dr Tingting Li and Dr Christina Mariyam Joy would like to gratefully acknowledge Dr Richard G. Phelps, Professor Andre A. Kaplan and Dr Michael S. Gersch, previous contributors to this topic. RGP and MSG declare that they have no competing interests. AAK has received honoraria in 2013 to speak about plasma exchange from Gambro and Alexion (Gambro manufactures products for plasma exchange and Alexion manufactures a complement cascade inhibitor).

Revisores

Dorin-Bogdan Borza, PhD

Assistant Professor of Medicine

Division of Nephrology

Department of Medicine

Vanderbilt University School of Medicine

Nashville

TN

Declarações

DBB declares that she has no competing interests.

O uso deste conteúdo está sujeito ao nosso aviso legal